Seer Inc
Update in progressSEER (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryBiotechnology
Seer, Inc. is a life sciences company that develops tools to study the proteome and advance human health. Its Proteograph Product Suite provides engineered nanoparticles, consumables, automation, and data software for proteomic analysis usable by most research labs. It also offers Proteograph ONE, Proteograph DIRECT, and Proteograph Analysis Suite (cloud). All products are for research use only. Headquartered in Redwood City, CA; founded 2017.
Company score
- Sentiment
- 0.05
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.41
- Governance
- -0.17
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.09
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.07
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGS (NMS)
- LocationUnited States
- CEODr. Omid C. Farokhzad M.D., Ph.D.
- Founded2017
- Employees124
- Websiteseer.bio
Identifiers
- ISINUS81578P1066
- FIGIBBG00HPLTRR8
- CUSIP81578P106
- CIK0001726445